Income Statement

AARDVARK THERAPEUTICS, INC.

AARD

Performance Overview Click any row in the table to add it to this chart

in millions USD

Metric	Dec 31, 2025 2025 FY
Revenue	-
Cost of Revenue	-
Gross Profit	-
Operating Expenses	62.73
Research & Development	48.94
Selling, General & Administrative	13.79
Other Operating Expenses	-
Operating Income	-62.73
Non-Operating Income	5.13
Interest Income	5.14
Interest Expense	-
Other Non-Op Income / Expense	-
Income Before Tax	-
Income Tax Expense	-
Non-Controlling Interest	-
Net Income	-57.59

Supplemental Per share data, derived & other items — not part of the income statement

in millions USD unless noted